GlassScriptPhysician profile
Duane D Galindo
NPI 1366861585
$822.32
in general payments reported to CMS, 2019-2025
11 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.03 · 2020: $123 · 2021: $77.55 · 2022: $136 · 2023: $78.42 · 2024: $62.28 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $278.70 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Angiodynamics, INC. | $138.25 | 2025 | Auryon Laser System 100-120 Vac |
| Paragon 28, INC. | $116.98 | 2022 | |
| Boston Scientific Corporation | $108.70 | 2020 | |
| Hartmann USA, INC. | $47.18 | 2025 | Zetuvit Plus 10x10 P10, Colactive Plus 2x2 |
| Smith+Nephew, INC. | $45.62 | 2019-2024 | Collagenase Santyl |
| Orthofix Medical, INC. | $37.26 | 2021-2025 | Physio-Stim |
| Convatec INC. | $16.69 | 2025 | |
| Grt US Holding, INC. | $16.24 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.46 | 2024 | Nuzyra |
| Advanced Oxygen Therapy INC. | $3.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Galindo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.